Sarcandrone B exhibits significant biological activity, particularly in anti-inflammatory and anticancer applications. It has been studied for its ability to inhibit the proliferation of certain cancer cell lines by inducing apoptosis and cell cycle arrest. Research also suggests it modulates key signaling pathways such as NF-κB and MAPK, which are involved in inflammation and tumor progression. Due to its natural origin and structural properties, it is considered a potential lead compound for developing novel therapeutic agents, especially in traditional medicine-based drug discovery. Additionally, it shows antioxidant properties that may contribute to its protective effects in cellular models.